LPW-E/1.2.3/324 — Prototype of a new drug formulation (Q3332925): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes) |
||||||||||
| Property / coordinate location | |||||||||||
54°21'20.95"N, 10°7'10.02"E
| |||||||||||
| Property / coordinate location: 54°21'20.95"N, 10°7'10.02"E / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 08:20, 5 November 2021
Project Q3332925 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LPW-E/1.2.3/324 — Prototype of a new drug formulation |
Project Q3332925 in Germany |
Statements
876,460.35 Euro
0 references
1,864,809.26 Euro
0 references
47.0 percent
0 references
1 December 2015
0 references
31 October 2020
0 references
PROTEO Biotech AG
0 references
54°21'20.95"N, 10°7'10.02"E
0 references
24106 Kiel
0 references
Entwicklung einer neuen pharmazeutischen Formulierung für die medizinische Anwendung bei schwerwiegenden Erkrankungen. (German)
0 references
Development of a new pharmaceutical formulation for medical use in serious diseases. (English)
25 October 2021
0 references
Identifiers
DE_TEMPORARY_35570
0 references